✦ LIBER ✦

Effectiveness and Safety of Laropiprant on Niacin-Induced Flushing

✍ Scribed by Darbie L. Maccubbin; Fabian Chen; Jennifer Weimer Anderson; Waheeda Sirah; Christine McCrary Sisk; Uma Kher; Anders G. Olsson; Harold E. Bays; Yale B. Mitchel

Book ID: 116207508
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 478 KB
Volume: 110
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2012.05.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Laropiprant on Nicotinic Acid

Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia

✍ John F. Paolini; Yale B. Mitchel; Robert Reyes; Uma Kher; Eseng Lai; Douglas J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 149 KB

The mechanism and mitigation of niacin-i

The mechanism and mitigation of niacin-induced flushing

✍ V. S. Kamanna; S. H. Ganji; M. L. Kashyap 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Effects of coadministered extended-relea

Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia

✍ Christie Ballantyne; Gilbert Gleim; Nancy Liu; Christine McCrary Sisk; Amy O. Jo 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 574 KB

Mechanisms of Flushing Due to Niacin and

Mechanisms of Flushing Due to Niacin and Abolition of These Effects

✍ Aditya Sood; Rohit Arora 📂 Article 📅 2009 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 124 KB

LIPID-ALTERING EFFICACY AND SAFETY PROFI

LIPID-ALTERING EFFICACY AND SAFETY PROFILE OF CO-ADMINISTERED EXTENDED RELEASE NIACIN/LAROPIPRANT AND SIMVASTATIN IN PATIENTS WITH DYSLIPIDEMIA

✍ Farnier, M.; Ose, L.; Gleim, G.; Liu, N.; Thompson-Bell, S.; Beckey, K.; Johnson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Niacin-induced flush as a measure of pro

Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics

✍ Paul Fiedler; Adam Wolkin; John Rotrosen 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 352 KB